Skip to main content

Table 4 Number of unique peptides and proteins measured within the FTD cohort

From: Distinct cell type-specific protein signatures in GRN and MAPT genetic subtypes of frontotemporal dementia

Brain area

Group

QC Condition

Peptides (n)

Proteins (n)

Frontal, Temporal

NDC, FTD-GRN, FTD-MAPT

50% of all samples

9,545

2,040

Frontal

NDC, FTD-GRN

50% of NDC or FTD-GRN

12,939

2,400

 

NDC, FTD-MAPT

50% of NDC or FTD-MAPT

11,958

2,346

Temporal

NDC, FTD-GRN

50% of NDC or FTD-GRN

9,425

2,037

 

NDC, FTD-MAPT

50% of NDC or FTD-MAPT

9,123

2,010

  1. Peptides and proteins are selected using quality value filtering on peptide level (see methods for details). Quality value peptide selection separated on brain area and FTD subtype gave the opportunity to analyse the highest number of proteins per statistical comparison